Immunogenicity animals polysaccharide-protein conjugate vaccine type III group Streptococcus native capsular polysaccharide type III group Streptococcus specific antibody response nonimmune human subjects immunogenicity polysaccharide type III polysaccharide toxoid Prior coupling aldehyde groups polysaccharide controlled periodate oxidation conversion sialic acid residues polysaccharide residues analogue sialic acid acid Tetanus toxoid polysaccharide reductive amination free aldehyde groups sialic acid residues Rabbits conjugate vaccine IgG antibodies native type III group streptococcal polysaccharide rabbits rabbits unconjugated type III polysaccharide rabbits Sera animals conjugate vaccine type III group streptococci phagocytic killing human peripheral blood leukocytes mice lethal challenge live type III group streptococci results method conjugation carrier protein useful strategy immunogenicity type III group Streptococcus polysaccharide human subjects 